Serum KL-6 level is increased in patients with pneumocystis pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 101s Year: 2006
Serum indicators for the diagnosis of pneumocystis pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 559s Year: 2006
High serum procalcitonin and C-reactive protein levels can exclude tuberculosis in community-acquired pneumonia patients with atypical presentation Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010
Serum levels of IL-6 in severe community-acquired pneumonia Source: Annual Congress 2010 - Pulmonary infections and sepsis Year: 2010
D-dimer elevation is associated with severity of community-acquired pneumonia according to CURB-65 and PSI Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia Year: 2006
Serum procalcitonin and community-acquired pneumonia in childhood Source: Eur Respir J 2005; 26: Suppl. 49, 167s Year: 2005
Admission CRP and D-dimer levels can identify high-risk patients with community-acquired pneumonia Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010
Serum procalcitonin concentrations in children with pulmonary tuberculosis, tuberculous infection and lober pneumonia Source: Eur Respir J 2003; 22: Suppl. 45, 176s Year: 2003
The influence of acute respiratory tract infection on the serum levels of KL-6 and SP-D in chronic interstitial pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 825s Year: 2006
YKL-40 and KL-6 in serum and sputum samples of patients diagnosed with hypersensitivity pneumonitis. Source: International Congress 2019 – Environment, work and respiratory health in occupational and environmental lung diseases Year: 2019
Annual changes of serum KL-6 were inversely correlated with those of respiratory function parameters in patients with nonspecific interstitial pneumonia Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010
Elevated troponin and creatinine levels are associated with higher mortality in community-acquired pneumonia Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools Year: 2010
Elevated levels of serum SP-A in chronic eosinophilic pneumonia Source: Eur Respir J 2001; 18: Suppl. 33, 409s Year: 2001
Serum procalcitonin (PCT) as a marker of the severity and prognosis of ventilator-associated pneumonia (VAP) Source: Annual Congress 2007 - Diagnostic markers and therapy in hospital-acquired pneumonia Year: 2007
Usefulness of serum cortisol in assessment for the severity of community-acquired pneumonia Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia Year: 2011
Serum procalcitonin and C-reactive protein in children with community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 488s Year: 2006
Diagnostic utility of serum KL-6 levels in acute respiratory failure with bilateral pulmonary infiltrates Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine Year: 2020
C-reactive protein as severity biomarker in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2005; 26: Suppl. 49, 545s Year: 2005
Serum KL-6 identifies ILD patients with a progressive fibrosing phenotype Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020
Serum interleukin-6 levels correlate with malnutrition in patients with acute exacerbation of COPD Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease Year: 2009